Differences in the dopaminergic effects of the ergot derivatives bromocriptine, lisuride and d-LSD as compared with apomorphine.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D001831:Body Temperature / Q000187:drug effects; D001971:Bromocriptine / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D004347:Drug Interactions; D004876:Ergot Alkaloids / Q000494:pharmacology*; D005260:Female; D008090:Lisuride / Q000494:pharmacology; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D012110:Reserpine / Q000494:pharmacology; D013469:Sulpiride / Q000494:pharmacology
D004876:Ergot Alkaloids; D008781:Methyltyrosines; D001971:Bromocriptine; D013469:Sulpiride; D012110:Reserpine; D008238:Lysergic Acid Diethylamide; D008090:Lisuride; D001058:Apomorphine; D004298:Dopamine